Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

A new compound effectively inhibits human 5α-reductase 1.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Testosterone's muscle-building effects do not require its conversion to DHT.

Hair loss drugs may cause sexual issues and infertility in men.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.